EARNINGS PER SHARE (Tables)

3 Months Ended

Mar. 29, 2026

Schedule of Earnings Per Share, Basic and Diluted

The following table reconciles the numerators and denominators used in the computations of both basic and diluted (loss) income per share:


(in millions, except share data)	Thirteen weeks ended March 29, 2026		Thirteen weeks ended March 30, 2025
Numerator:
Net (loss) income attributable to common stockholders	$	(1.7)	$	7.5
Denominator:
Weighted average Class A Common Stock shares, basic	88,347,854		85,721,393
Dilutive securities included in diluted earnings per share calculation:
Warrants	—		1,204,562
RSUs	—		392,877
PSUs	—		215,687
Stock options	—		821
Total dilutive weighted average shares	88,347,854		87,535,340
Basic (loss) income per share	$	(0.02)	$	0.09
Diluted (loss) income per share	$	(0.02)	$	0.09
Weighted average Class V Common Stock not subject to earnings per share calculation	55,349,000		55,656,692
Net loss attributable to noncontrolling interest	$	(0.7)	$	(1.8)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The diluted earnings per share computation includes the effect of the 7,200,000 private placement warrants (the "Warrants") for the period in which they were outstanding. The Warrants were fully exercised in a cashless exchange in August 2025, resulting in the issuance of 1,307,873 shares of the Company's Class A Common Stock. The diluted earnings per share computation excludes the effect of certain restricted stock units ("RSUs"), performance stock units ("PSUs") and stock options granted to directors and management that convert to Class A Common Stock upon vesting or being exercised, as their inclusion would have been anti-dilutive. Anti-dilutive securities excluded from diluted income per share calculations are as follows:


	Thirteen weeks ended March 29, 2026	Thirteen weeks ended March 30, 2025

RSUs	1,315,958	400,612
PSUs	834,600	411,990
Stock options	649,930	633,007